e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Inflammatory mechanisms in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Transforming growth factor-beta1 (TGF-β1) expression is related to reticular basement membrane (Rbm) hypervascularity in smokers and COPD
S.S. Sohal, A. Soltani, D. Reid, S. Weston, H.K. Muller, R. Wood-Baker, E.H. Walters (Hobart, Brisbane, Australia)
Source:
Annual Congress 2012 - Inflammatory mechanisms in COPD
Session:
Inflammatory mechanisms in COPD
Session type:
Thematic Poster Session
Number:
782
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S.S. Sohal, A. Soltani, D. Reid, S. Weston, H.K. Muller, R. Wood-Baker, E.H. Walters (Hobart, Brisbane, Australia). Transforming growth factor-beta1 (TGF-β1) expression is related to reticular basement membrane (Rbm) hypervascularity in smokers and COPD. Eur Respir J 2012; 40: Suppl. 56, 782
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Expression of transforming growth factor (TGF) in bronchial epithelium: association with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 92s
Year: 2001
Wnt11 inhibits effects of transforming growth factor-beta1 (TGFbeta1) on lung epithelial phenotype
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma
Source: Eur Respir J 2006; 27: 208-229
Year: 2006
Transforming growth factor-beta1 (TGF-beta1) gene polymorphism in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006
Expression of basic fibroblast growth factor (bFGF) in smokers with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 454s
Year: 2004
Transforming growth factor-β induces collagen synthesis without inducing IL-8 production in mesothelial cells
Source: Eur Respir J 2003; 22: 197-202
Year: 2003
Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF
Source: Eur Respir J 2001; 17: 1220-1227
Year: 2001
Transforming Growth factor beta-1 and Smad signaling has the potential to drive EMT-related changes in smokers and COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Transforming growth factor-β as a differentiating factor for cultured smooth muscle cells
Source: Eur Respir J 2007; 30: 643-652
Year: 2007
Transforming growth factor-beta 1 (TGF-beta1) gene polymorphism in coincidence with some other host and environmental factors is associated with irreversible bronchoconstriction in asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Epidermal growth factor (EGF) and its receptors (ERBBs) in smokers with and without COPD: An index of epithelial repair imbalance?
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
Matrix metalloproteinase-9 (MMP-9) and transforming growth factor β1 (TGF β1) levels in induced sputum and serum samples of mild and severe asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 163s
Year: 2001
Transforming growth factor beta 1 (TGF-ß1) level as a marker of COPD severity
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
The role of integrins in pulmonary fibrosis
Source: Eur Respir Rev 2008; 17: 157-162
Year: 2008
Increased expression of epidermal growth factor-receptor in idiopathic interstitial pneumonias. A tissue microarray study
Source: Eur Respir J 2007; 30: Suppl. 51, 573s
Year: 2007
Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Connective tissue growth factor and transforming growth factor β induces extracellular matrix in asthmatic airway smooth muscle
Source: Eur Respir J 2005; 26: Suppl. 49, 712s
Year: 2005
Influence of tobacco-smoking on serum level of transforming growth factor (TGF) beta 1 in COPD patients
Source: International Congress 2017 – COPD biomarkers
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept